We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 20

Holstering the hired guns: the medical expert’s duty is to the court, not the litigant
  • Gowling WLG
  • USA
  • October 13 2011

At issue before Master Short was a motion by the plaintiff for an undertaking requiring the defendant to make concurrent disclosure of any medical surveillance provided to its expert to the plaintiff.


FDA requires increased disclosure of bioequivalence studies for ANDA applicants
  • Gowling WLG
  • USA
  • February 9 2009

Effective July 15, 2009, the U.S. Food and Drug Administration (FDA) will require applicants of an abbreviated new drug application (ANDA) to submit all data from bioequivalence studies that have been conducted on the particular drug formulation submitted for approval.


Stem cell patents challenged
  • Gowling WLG
  • USA
  • July 13 2007

Earlier this year, the U.S. Patent and Trademark Office (“USPTO”) released a preliminary decision indicating that patents covering human embryonic stem cells are not inventive and that it may throw them out.



Scott E. Foster
  • Gowling WLG


Kieran Laird
  • Gowling WLG

Livia Aumand
  • Gowling WLG